Work

Molecular, immune and histopathological characterization of NSCLC based on PDL1 expression on tumor and immune cells and association with response to the anti-PDL1 antibody MPDL3280A.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.3015

Authors: Scott N. Gettinger, Marcin Kowanetz, Hartmut Koeppen, Ignacio Ivan Wistuba, Mark Kockx, Edward E. Kadel, Naiyer A. Rizvi, Alexander I. Spira, Fred R. Hirsch, Zachary Boyd, Mitchell Denker, Alexandra Minn, David S. Shames, Alan Sandler, Daniel S. Chen, Priti S. Hegde, David R. Spigel

Institutions: Yale University, Genentech, The University of Texas MD Anderson Cancer Center, HistoGeneX (Belgium), Columbia University Irving Medical Center, Virginia Cancer Specialists, University of Colorado Cancer Center, Sarah Cannon

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2518431739

Cites:

Cited by: 12

Related to: 10